Clinical experiences with vecuronium in children

Related Experiment Videos

M P De1, A K Paul

  • 1Department of Anaesthesiology, Medical College and Hospitals, Calcutta.

Insights

Vecuronium is a safe and effective muscle relaxant for endotracheal intubation in children. A dose of 0.1 mg/kg provided optimal conditions for intubation with minimal side effects.

Area of Science:

  • Anesthesiology
  • Pediatric Pharmacology

Background:

  • Neuromuscular blocking agents are crucial in pediatric anesthesia.
  • Vecuronium is a non-depolarizing neuromuscular blocker with established use.

Purpose of the Study:

  • To evaluate the efficacy and safety of vecuronium for endotracheal intubation in children.
  • To determine the optimal dose for pediatric anesthesia.

Main Methods:

  • A clinical study involving 40 pediatric patients.
  • Administration of vecuronium at two doses: 0.08 mg/kg and 0.1 mg/kg body weight.
  • Single intravenous bolus injection for endotracheal intubation.

Main Results:

  • The 0.1 mg/kg dose of vecuronium ensured satisfactory clinical relaxation for ideal intubation in all patients.
  • Key benefits included ease of intubation, intermediate duration of action, and smooth reversal.
  • Cardiovascular stability and absence of serious adverse events were observed.

Conclusions:

  • Vecuronium, at a dose of 0.1 mg/kg, is a useful and safe muscle relaxant in pediatric anesthesia.
  • It facilitates effective endotracheal intubation with a favorable safety profile.

Related Concept Videos